Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 90

1.

Phenotyping non-alcoholic fatty liver disease by the gut microbiota - ready for prime time?

Demir M, Lang S, Martin A, Farowski F, Wisplinghoff H, Vehreschild MJGT, Krawczyk M, Nowag A, Scholz CJ, Kretzschmar A, Roderburg C, Lammert F, Goeser T, Kasper P, Steffen HM.

J Gastroenterol Hepatol. 2020 Apr 8. doi: 10.1111/jgh.15071. [Epub ahead of print]

PMID:
32267559
2.

Primary Neuroendocrine Neoplasms of the Breast: Case Series and Literature Review.

Özdirik B, Kayser A, Ullrich A, Savic LJ, Reiss M, Tacke F, Wiedenmann B, Jann H, Roderburg C.

Cancers (Basel). 2020 Mar 20;12(3). pii: E733. doi: 10.3390/cancers12030733. Review.

3.

Circulating levels of soluble urokinase plasminogen activator receptor predict outcome after resection of biliary tract cancer.

Loosen SH, Breuer A, Tacke F, Kather JN, Gorgulho J, Alizai PH, Bednarsch J, Roeth AA, Lurje G, Schmitz SM, Brozat JF, Paffenholz P, Vucur M, Ritz T, Koch A, Trautwein C, Ulmer TF, Roderburg C, Longerich T, Neumann UP, Luedde T.

JHEP Rep. 2020 Jan 31;2(2):100080. doi: 10.1016/j.jhepr.2020.100080. eCollection 2020 Apr.

4.

Current status of immunotherapy in gastrointestinal malignancies.

Lorenzen S, Lordick F, Loosen SH, Tacke F, Trautwein C, Roderburg C, Ettrich TJ, Perkhofer L, Reinacher-Schick A, Stein A.

Z Gastroenterol. 2020 Feb 4. doi: 10.1055/a-1071-8322. [Epub ahead of print]

PMID:
32018315
5.

Evaluating hepatotoxic effects of chemotherapeutic agents with gadoxetic-acid-enhanced magnetic resonance imaging.

Theilig D, Elkilany A, Jann H, Roderburg C, Hamm B, Fehrenbach U, Geisel D.

Eur J Radiol. 2020 Mar;124:108807. doi: 10.1016/j.ejrad.2019.108807. Epub 2019 Dec 31.

PMID:
31926386
6.

New drugs for NAFLD: lessons from basic models to the clinic.

Reimer KC, Wree A, Roderburg C, Tacke F.

Hepatol Int. 2020 Jan;14(1):8-23. doi: 10.1007/s12072-019-10001-4. Epub 2019 Dec 4. Review.

PMID:
31802390
7.

Serum Levels of Kisspeptin Are Elevated in Patients with Pancreatic Cancer.

Loosen SH, Luedde M, Lurje G, Spehlmann M, Paffenholz P, Ulmer TF, Tacke F, Vucur M, Trautwein C, Neumann UP, Luedde T, Roderburg C.

Dis Markers. 2019 Oct 20;2019:5603474. doi: 10.1155/2019/5603474. eCollection 2019.

8.

Serum Levels of miR-143 Predict Survival in Critically Ill Patients.

Roderburg C, Koch A, Benz F, Vucur M, Spehlmann M, Loosen SH, Luedde M, Rehse S, Lurje G, Trautwein C, Tacke F, Luedde T.

Dis Markers. 2019 Oct 23;2019:4850472. doi: 10.1155/2019/4850472. eCollection 2019.

9.

[Unknown liver lesions].

Roderburg C, Loosen SH, Bruners P, Luedde T.

Dtsch Med Wochenschr. 2019 Nov;144(23):1651-1664. doi: 10.1055/a-0733-6122. Epub 2019 Nov 21. German.

PMID:
31752038
10.

A Combined Score of Circulating miRNAs Allows Outcome Prediction in Critically Ill Patients.

Roderburg C, Benz F, Koch A, Loosen SH, Spehlmann M, Luedde M, Wree A, Vucur M, Trautwein C, Tacke F, Luedde T.

J Clin Med. 2019 Oct 9;8(10). pii: E1644. doi: 10.3390/jcm8101644.

11.

Sarcopenia Is a Negative Prognostic Factor in Patients Undergoing Transarterial Chemoembolization (TACE) for Hepatic Malignancies.

Loosen SH, Schulze-Hagen M, Bruners P, Tacke F, Trautwein C, Kuhl C, Luedde T, Roderburg C.

Cancers (Basel). 2019 Oct 8;11(10). pii: E1503. doi: 10.3390/cancers11101503.

12.

The Role of Adipokines as Circulating Biomarkers in Critical Illness and Sepsis.

Loosen SH, Koch A, Tacke F, Roderburg C, Luedde T.

Int J Mol Sci. 2019 Sep 28;20(19). pii: E4820. doi: 10.3390/ijms20194820. Review.

13.

Erratum: Hohlstein, P. et al. Prognostic Relevance of Altered Lymphocyte Subpopulations in Critical Illness and Sepsis. Journal of Clinical Medicine 2019, 8, 353.

Hohlstein P, Gussen H, Bartneck M, Warzecha KT, Roderburg C, Buendgens L, Trautwein C, Koch A, Tacke F.

J Clin Med. 2019 Aug 23;8(9). pii: E1296. doi: 10.3390/jcm8091296.

14.

Excellent Response to Anti-PD-1 Therapy in a Patient with Hepatocellular Carcinoma Intolerant to Sorafenib.

Roderburg C, Berres ML, Wree A, Loosen SH, Luedde T, Trautwein C.

Visc Med. 2019 Mar;35(1):43-46. doi: 10.1159/000497465. Epub 2019 Feb 12.

15.

Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future.

Stueven AK, Kayser A, Wetz C, Amthauer H, Wree A, Tacke F, Wiedenmann B, Roderburg C, Jann H.

Int J Mol Sci. 2019 Jun 22;20(12). pii: E3049. doi: 10.3390/ijms20123049. Review.

16.

Faecal Micro-RNAs in Inflammatory Bowel Diseases.

Verdier J, Breunig IR, Ohse MC, Roubrocks S, Kleinfeld S, Roy S, Streetz K, Trautwein C, Roderburg C, Sellge G.

J Crohns Colitis. 2020 Jan 1;14(1):110-117. doi: 10.1093/ecco-jcc/jjz120.

PMID:
31209454
17.

The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.

Lurje G, Bednarsch J, Czigany Z, Lurje I, Schlebusch IK, Boecker J, Meister FA, Tacke F, Roderburg C, Den Dulk M, Gaisa NT, Bruners P, Neumann UP.

Eur J Surg Oncol. 2019 Aug;45(8):1468-1478. doi: 10.1016/j.ejso.2019.04.019. Epub 2019 Apr 25.

PMID:
31053477
18.

miR-155 Predicts Long-Term Mortality in Critically Ill Patients Younger than 65 Years.

Tacke F, Spehlmann ME, Vucur M, Benz F, Luedde M, Cardenas DV, Roy S, Loosen S, Hippe HJ, Frey N, Trautwein C, Koch A, Roderburg C, Luedde T.

Mediators Inflamm. 2019 Feb 24;2019:6714080. doi: 10.1155/2019/6714080. eCollection 2019.

19.

Treatment Strategies for Hepatocellular Carcinoma ⁻ a Multidisciplinary Approach.

Lurje I, Czigany Z, Bednarsch J, Roderburg C, Isfort P, Neumann UP, Lurje G.

Int J Mol Sci. 2019 Mar 22;20(6). pii: E1465. doi: 10.3390/ijms20061465. Review.

20.

Prognostic Relevance of Altered Lymphocyte Subpopulations in Critical Illness and Sepsis.

Hohlstein P, Gussen H, Bartneck M, Warzecha KT, Roderburg C, Buendgens L, Trautwein C, Koch A, Tacke F.

J Clin Med. 2019 Mar 12;8(3). pii: E353. doi: 10.3390/jcm8030353. Erratum in: J Clin Med. 2019 Aug 23;8(9):.

Supplemental Content

Loading ...
Support Center